Monte S. Meltzer
#139,134
Most Influential Person Now
Monte S. Meltzer's AcademicInfluence.com Rankings
Monte S. Meltzerbiology Degrees
Biology
#9744
World Rank
#12986
Historical Rank
Parasitology
#31
World Rank
#39
Historical Rank
Microbiology
#534
World Rank
#596
Historical Rank
Immunology
#589
World Rank
#608
Historical Rank
Download Badge
Biology
Monte S. Meltzer's Degrees
- Masters Biology Stanford University
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Monte S. Meltzer Influential?
(Suggest an Edit or Addition)Monte S. Meltzer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. (1990) (730)
- Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. (1990) (458)
- Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. (1988) (383)
- The macrophage in the persistence and pathogenesis of HIV infection. (1989) (373)
- Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study (1988) (306)
- B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. (1987) (294)
- Live vaccine strain of Francisella tularensis: infection and immunity in mice (1991) (286)
- Cytokine‐Induced Synthesis of Nitrogen Oxides in Macrophages: A Protective Host Response to Leishmania and Other Intracellular Pathogens (1991) (275)
- Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. (1990) (274)
- Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. (1978) (253)
- Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. (1990) (199)
- Tumor-specific antigen solubilized by hypertonic potassium chloride. (1971) (181)
- Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth (1995) (175)
- Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells. (1977) (175)
- Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG. (1974) (172)
- Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. (1981) (167)
- Macrophages and the human immunodeficiency virus. (1990) (158)
- Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. (1978) (147)
- Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. (1991) (143)
- Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. (1988) (142)
- Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells. (1975) (141)
- Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. (1990) (138)
- Interferons in the persistence, pathogenesis, and treatment of HIV infection. (1992) (131)
- Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. (1990) (127)
- Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures. (1977) (127)
- Defective tumoricidal capacity of macrophages from C3H/HeJ mice. (1978) (125)
- Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice (1993) (125)
- Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines. (1985) (122)
- Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages. (1981) (122)
- Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. (1976) (121)
- Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. (1994) (118)
- Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene. (1978) (102)
- Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages. (1994) (100)
- Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi. (1979) (99)
- Interaction of BCG-activated macrophages with neoplastic and noneoplastic cell lines in vitro: cinemicrographic analysis. (1975) (99)
- Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4. (1989) (98)
- Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. (1992) (95)
- A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes [published erratum appears in J Exp Med 1991 Jan 1;173(1):277] (1990) (89)
- Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli. (1978) (85)
- IL-2. A cofactor for induction of activated macrophage resistance to infection. (1990) (81)
- A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes (1991) (81)
- Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. (1992) (80)
- Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells (1980) (78)
- Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. (1982) (78)
- T-cell-mediated activation of macrophages. (1991) (73)
- Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120 (1992) (71)
- Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. (1993) (71)
- Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages. (1981) (68)
- Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. (1990) (68)
- Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells. (1978) (67)
- Biological Effects of Lymphocyte and Macrophage-Derived Mitogenic “Amplication” Factors (1979) (66)
- Epidermal Langerhans cells are not principal reservoirs of virus in HIV disease. (1991) (63)
- Macrophages as effector cells of protective immunity in murine schistosomiasis. (1982) (62)
- Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum (1983) (61)
- The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice. (1989) (59)
- Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection. (1982) (59)
- Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens. (1972) (58)
- Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN. (1992) (57)
- Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor (1981) (56)
- Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains. (1979) (56)
- Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. (1977) (56)
- Macrophage activation for tumor cytotoxicity: regulatory mechanisms for induction and control of cytotoxic activity. (1982) (54)
- Regulation of interferon‐α‐inducible cellular genes in human immunodeficiency virus‐infected monocytes (1994) (53)
- Macrophage function in tumor-bearing mice: dissociation of phagocytic and chemotactic responsiveness. (1978) (52)
- Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. (1979) (52)
- Macrophage activation for tumor cytotoxicity: Induction of tumoricidal macrophages by PPD in BCG-immune mice (1977) (51)
- PERITONEAL MONONUCLEAR PHAGOCYTES FROM SMALL ANIMALS (1981) (51)
- No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytes. (1992) (50)
- Increased chemotactic responses of macrophages from BCG-infected mice. (1975) (49)
- Infection of human gastrointestinal cells by HIV-1. (1990) (48)
- A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro. (1986) (47)
- Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity. (1996) (47)
- Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. (1994) (47)
- Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. (1990) (47)
- Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma. (1985) (46)
- Macrophage activation: a riddle of immunological resistance. (1994) (46)
- Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages. (1975) (44)
- Tumour necrosis factor (TNF) as a mediator of macrophage helminthotoxic activity (1990) (43)
- The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo (1991) (43)
- Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line (1983) (42)
- Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice (1987) (42)
- Role of macrophage lipids in regulating tumoricidal activity. (1983) (42)
- Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. (1983) (41)
- Depressed chemotactic responses in vitro of peritoneal macrophages from tumor-bearing mice. (1976) (40)
- Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. (1995) (40)
- Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition. (1986) (39)
- Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities. (1983) (39)
- Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets. (1984) (39)
- Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. (1979) (38)
- Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG. (1977) (37)
- Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. (1991) (37)
- Interactions between HIV‐infected monocytes and the extracellular matrix: HIV‐infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices (1992) (37)
- Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. (1980) (36)
- Tumor regression after intralesional injection of emulsified trehalose‐6,6′‐dimycolate (cord factor): Efficacy increases with oil concentration (1977) (36)
- Immunopathogenesis of human immunodeficiency virus infection in the central nervous system (1988) (34)
- Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells. (1983) (33)
- Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells. (1972) (33)
- Protective tumor immunity induced by potassium chloride extracts of guinea pig hepatomas. (1975) (32)
- Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection. (1988) (32)
- Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes. (1985) (32)
- Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets. (1981) (31)
- Killing of Leishmania tropica amastigotes by factors in normal human serum. (1984) (31)
- Binding of recombinant HIV coat protein gp120 to human monocytes. (1991) (31)
- Macrophages as effector cells of protective immunity in murine schistosomiasis. IV. Coincident induction of macrophage activation for extracellular killing of schistosomula and tumor cells. (1982) (31)
- Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes. (1980) (31)
- Characterization of mouse lymphocyte-derived chemotactic factor. (1976) (29)
- Tumor-specific, cell-mediated immunity in guinea pigs with tumors. (1973) (29)
- Tumor suppression by Mycobacterium bovis (strain BCG) enhanced by vitamin A. (1974) (29)
- Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. (1980) (28)
- Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions. (1979) (27)
- Interferon‐γ protects primary monocytes against infection with human immunodeficiency virus type 1 (1994) (26)
- Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stage. (1982) (26)
- Brief Communication: Mouse Mononuclear Cell Chemotaxis: Description of System (1975) (26)
- Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDa lipopolysaccharide receptor. (1992) (26)
- The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG. (1981) (26)
- Macrophages in Resistance to Rickettsial Infections: Protection Against Lethal Rickettsia tsutsugamushi Infections by Treatment of Mice With Macrophage‐Activating Agents (1984) (23)
- Interactions between HIV‐infected monocytes and the extracellular matrix: increased capacity of HIV‐infected monocytes to adhere to and spread on extracellular matrix associated with changes in extent of virus replication and cytopathic effects in infected cells (1992) (23)
- Effects of colony stimulating factors on the interaction of monocytes and the human immunodeficiency virus. (1988) (22)
- Macrophages in resistance to rickettsial infection: susceptibility to lethal effects of Rickettsia akari infection in mouse strains with defective macrophage function. (1980) (21)
- Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities. (1991) (21)
- Mononuclear phagocytes and the human immunodeficiency virus. (1990) (21)
- Monocytes, dendritic cells, and Langerhans cells in human immunodeficiency virus infection. (1991) (21)
- Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues. (1973) (21)
- Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines. (1979) (21)
- Enhanced tumor growth in animals pretreated with complete Freund's adjuvant. (1973) (20)
- Macrophages in resistance to rickettsial infection: strains of mice susceptible to the lethal effects of Rickettsia akari show defective macrophage Rickettsicidal activity in vitro (1982) (20)
- Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease. (1992) (19)
- Genetic Control of Macrophage Activation for Killing of Extracellular Targets (1984) (18)
- Phorbol ester reduces constitutive nuclear NFχB and inhibits HIV‐1 production in mature human monocytic cells (1992) (17)
- Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing (1985) (17)
- Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis (1993) (15)
- Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. (1984) (15)
- Effects of gases upon cell growth; quantitative studies on multiplication of monolayer cultures of human lens epithelium L-Strain, and chick heart fibroblasts under various gaseous environments. (1960) (14)
- Loss ability to produce IFN-alpha in response to HIV-1 as monocytes differentiate into macrophages. Induction through a mechanism independent of double-stranded RNA. (1996) (14)
- Role of membrane lipids in the immunological killing of tumor cells: II. Effector cell lipids (1983) (14)
- HIV infection of the lung. Role of virus-infected macrophages in the pathophysiology of pulmonary disease. (1993) (14)
- Increased Efficacy of Human Natural Interferon α (IFN-αn3) Versus Human Recombinant IFN-α2 for Inhibition of HIV-1 Replication in Primary Human Monocytes (1993) (14)
- Properties of tumor-specific antigen solubilized by hypertonic potassium chloride. (1972) (14)
- Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. (1979) (13)
- Differential cytotoxicity of tumorigenic and nontumorigenic strain-2 guinea pig cells as mediated by syngeneic phytohemagglutinin-stimulated peritoneal exudate cells. (1975) (13)
- Chemotactic response of mouse macrophages to culture fluids mitogen-stimulated spleen cells. (1976) (13)
- Defective spontaneous but normal antibody-dependent cytotoxicity for an extracellular protozoan parasite, Giardia lamblia, by C3H/HeJ mouse macrophages. (1984) (13)
- Transfection of human immunodeficiency virus type 1 proviral DNA into primary human monocytes. (1993) (12)
- Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice. (1978) (12)
- USE OF PEROXIDASE STAIN BY THE KAPLOW METHOD (1981) (12)
- Interferon‐γ inhibits HIV‐induced invasiveness of monocytes (1995) (12)
- Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice (1976) (12)
- Mouse mononuclear cell chemotaxis: description of system. (1975) (11)
- Differential inhibition of macrophage microbicidal activity by liposomes (1985) (11)
- Susceptibility of inbred mice to Leishmania tropica infection: genetic control of the development of cutaneous lesions in P/J mice. (1984) (11)
- Macrophages in resistance to rickettsial infections: genetic analysis of susceptibility to lethal effects of Rickettsia akari infection and development of activated, cytotoxic macrophages in A and B10.a mice. (1982) (10)
- Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus. (1991) (10)
- Macrophage activation for tumor cytotoxicity: control of cytotoxic activity by the time interval effector and target cells are exposed to lymphokines. (1981) (10)
- PERITONEAL MACROPHAGES FROM BCG-INFECTED MICE: TUMOR CYTOTOXICITY AND CHEMOTACTIC RESPONSES IN VITRO (1976) (9)
- CYTOLYSIS OF TUMOR CELLS BY RELEASE OF [3H−] THYMIDINE (1981) (9)
- Lymphokine regulation of macrophage effector activities. (1988) (9)
- Inhibition of interferon γ-induced macrophage microbicidal activity against Leishmania major by liposomes: Inhibition is dependent upon composition of phospholipid headgroups and fatty acids (1989) (8)
- HIV Infection of the Lung: Role of Virus-infected Macrophages in the Pathophysiology of Pulmonary Disease (1993) (7)
- Functional Characterization of Lymphokines From the EL‐4 T Cell Line That Activate Macrophages for Nonspecific Tumor Cytotoxicity (1984) (7)
- Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex. (1985) (7)
- Experimental variables for induction of activated cytotoxic macrophages. (1986) (6)
- ACTIVATED MACROPHAGES IN NATURAL RESISTANCE TO RICKETTSIA AKARI (1980) (5)
- Histopathology of tumor regression by cord factor, turpentine or endotoxin, dissociation of therapy and granuloma formation. (1979) (5)
- MACROPHAGE ACTIVATION FOR TUMOR CYTOTOXICITY: GENETIC INFLUENCES ON DEVELOPMENT OF MACROPHAGES WITH NONSPECIFIC TUMORICIDAL ACTIVITY (1980) (5)
- Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation. (1981) (5)
- Susceptibility to killing by bcg‐activated macrophages associated with ‘spontaneous’ neoplastic transformation in culture (1981) (5)
- Chlamydial and Rickettsial Infections (1989) (4)
- Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes. (1993) (4)
- Activation of macrophages for killing of rickettsiae: analysis of macrophage effector function after rickettsial inoculation of inbred mouse strains. (1983) (4)
- Molecular weight, isoelectric point, and stability of a murine lymphokine that induces macrophage tumoricidal activity. (1983) (4)
- Leucocyte migration test in patients after corneal transplantation. (1976) (4)
- Chemotactic Activity of Bone Marrow-Derived Macrophages Changes with Time in Culture (1981) (4)
- Immunoprophylaxis in BALB/c mice: a model for development of protection against primary and secondary infection with Leishmania major. (1985) (3)
- Interactions between interferon and the human immunodeficiency virus. (1990) (3)
- Intercellular communication: macrophages and cytokines. (1990) (3)
- Regulation of HIV replication in monocytes by interferon. (1994) (2)
- Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma. (1987) (2)
- Defective macrophage chemotaxis in tumor-bearing mice. Abstr. (1975) (2)
- Alteration of macrophage function in mice with transplantable tumors: evidence for virus-induced changes. Abstr. (1979) (2)
- Cellular and cytokine networks in tissue immunity : proceedings of the 12th International RES Congress and the 27th Annual Meeting of the Society for Leukocyte Biology, held in Heraklion, Crete, Greece, October 14-18, 1990 (1991) (2)
- Transient Cytotoxic Responses of Activated Macrophages: Characterization of Signals that Regulate Cytotoxic Activity (1983) (2)
- Mouse Mononuclear Cell Chemotaxis (1975) (1)
- Macrophage activation factor from EL-4 cells distinct from murine gamma interferon (IFN) (1985) (1)
- Lymphokine-induced macrophage resistance to infection with Leishmania major. (1988) (1)
- EFFECTS OF HUSBANDRY AND MOUSE STRAINS ON MONONUCLEAR PHAGOCYTES (1981) (1)
- Activated macrophage-lymphocyte interaction through soluble mediators (1976) (1)
- EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR ON PERITONEAL EXUDATE CELLS OF C3H/HeN AND C3H/HeJ MICE (1978) (1)
- Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody. (1976) (1)
- Regulation of macrophage antimicrobial activities by lymphocyte products (1986) (1)
- Inhibition of interferon gamma-induced macrophage microbicidal activity against Leishmania major by liposomes: inhibition is dependent upon composition of phospholipid headgroups and fatty acids. (1989) (1)
- Macrophage activation factors derived from a continuous T-cell line☆☆☆ (1982) (1)
- Macrophage activation for tumor cytotoxicity: reactivity of peritoneal and bone marrow macrophages. (1982) (1)
- Role of Macrophages and Dendritic Cells in Contact Dermatitis (1994) (1)
- USE OF WRIGHT'S STAIN AND CYTOCENTRIFUGE PREPARATIONS (1981) (1)
- Defective induction of macrophage microbicidal activity with p/n lymphokines. Abstr. (1982) (1)
- Regulation of macrophage effector function by B cell stimulatory factor-1 (BSF-1). (1988) (1)
- Suppression of rickettsial growth in macrophages activated by antigen-stimulated spleen cell supernatants. Abstr. (1978) (1)
- Bcg activated macrophages in tumor bearing mice. Abstr. (1976) (0)
- Regulation of macrophage (MØ) activation by endogenous mediators (1982) (0)
- Defective response to migration inhibition factor by peritoneal macrophages from c3h/hej mice. Abstr. (1978) (0)
- Leishmania (2002) (0)
- Symposium: The role of macrophages in tumor immunology. (1979) (0)
- Defective tumoricidal capacity of macrophages from a-derived strains of mice. Abstr. (1978) (0)
- Human Immunodeficiency Virus (HIV) Genes in Human Monocytes (1993) (0)
- Phase I Trial of Interferon Alfa-n3 (IFN-αn3) In Early-Stage HIV-1 Disease (1995) (0)
- Macrophages from mice infected with schistosoma mansoni exhibit enhanced tumoricidal activity. Abstr. (1981) (0)
- Ocular Tumor Associated CD11b+ Myeloid Cells Inhibit CD8+ CTL Responses via Nitric Oxide Production (2007) (0)
- Immunity to rickettsia tsutsugamushi infection induced by nonspecific macrophage activating agents. Abstr. (1979) (0)
- Genetic analysis of the macrophage tumoricidal defect of a/j mice. Abstr. (1979) (0)
- Macrophage activation for tumor cytotoxicity depends upon genetic factors. Abstr. (1979) (0)
- Lymphokine activation of mouse peritoneal macrophages for killing of leishmania tropica. Abstr. (1980) (0)
- ROLE OF ACTIVATED MACROPHAGES IN RESISTANCE TO RICKETTSIAL INFECTIONS (1982) (0)
- Macrophage activation for tumor cytotoxicity. Evidence for a two step reaction. Abstr. (1978) (0)
- Cytokine and viral gene expression during infection of monocytes by the human immunodeficiency virus: central role of interferons in the promotion and resolution of virus infection (1992) (0)
- Characterizationof MacrophageChemotaxinsin Tumor Cell Cultures and Comparisonwith Lymphocyte-derived ChemotacticFactors (1977) (0)
- Resistance of c3h/hej mice to infection with listeria monocytogenes. Abstr. (1979) (0)
- Effects of infectious lactic dehydrogenase-elevating virus (LDV) and tumors on macrophage function in mice. (1980) (0)
- Generation andCharacterization ofaLipopolysaccharide- Induced andSerum-Derived Cytotoxic Factor forTumorCells (1980) (0)
- Increased reactivity to lymphokines of macrophages from tumor-bearing mice. Abstr. (1977) (0)
- Tumor cell chemotactic factor for mouse macrophages. Abstr. (1976) (0)
- IFNγ and LK factors that induce intracellular destruction of Leishmania amastigotes activate macrophages by independent pathways (1985) (0)
- Summary of National Meeting of the Society for Leukocyte Biology (27th) (A Reticuloendothelial Society) (1991) (0)
- SerumContaining TumorNecrosis Factor IsCytotoxic forthe HumanMalaria Parasite Plasmodium falciparum (1983) (0)
- Spontaneous activation of bone marrow derived lymphocytes and macrophages in young new zealand black mice (1977) (0)
- LossofInfectivity byProgeny VirusfromAlphaInterferon- Treated HumanImmunodeficiency VirusType1-Infected T Cells IsAssociated withDefective Assembly ofEnvelope gpl20 (1992) (0)
- DEFECTIVE TUMORICIDAL CAPACITY OF MACROPHAGES FROM P/J MICE: TUMORICIDAL DEFECT INVOLVES ABNORMALITIES IN MONONUCLEAR PHAGOCYTE RESPONSIVENESS LYMPHOKINE-DERIVED ACTIVATION STIMULI AND IN (1980) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Monte S. Meltzer?
Monte S. Meltzer is affiliated with the following schools:
